The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma

Bulletin du Cancer

Volumn 99, Issue 3, 2012, Pages

  Li, Hua ^a   Fang, Ling ^a   Xiao, Xigang ^a   Shen, Lei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antiapoptosis; Antisense oligonucleotides; CABYR c; Hepatocellular carcinoma; HepG2

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE;

APOPTOSIS; ARTICLE; CABYR GENE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DOSE RESPONSE; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84863361848     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1538     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60 : 277-300.
2. Ueda H, Ullrich SJ, Gangemi JD, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995; 9 : 41-7.
3. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991; 51 : 5520-5.
4. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31 : 339-46. (Pubitemid 35154440)
5. Hsu T, Moroy T, Etiemble J, et al. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 1988; 55 : 627-35.
6. Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 1989; 80 : 196-9. (Pubitemid 20027206)
7. Takahashi M, Saito H, Okuyama T, et al. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis. J Hepatol 1999; 31 : 315-22. (Pubitemid 29349759)
8. Lian Z, Liu J, Pan J, et al. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology 2001; 34 : 146-57. (Pubitemid 32591495)
9. Otsuka M, Kato N, Taniguchi H, et al. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology 2002; 296 : 84-93.
10. Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995; 14 : 4747-57.
11. Natoli G, Avantaggiati ML, Chirillo P, et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol 1994; 14 : 989-98. (Pubitemid 24036549)
12. Lee YH, Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 1998; 273 : 25510-5. (Pubitemid 28443322)
13. Naaby-Hansen S, Mandal A, Wolkowicz MJ, et al. CABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous sheath protein involved in capacitation. Dev Biol 2002; 242 : 236-54. (Pubitemid 34163983)
14. Sen B, Mandal A, Wolkowicz MJ, et al. Splicing in murine CABYR and its genomic structure. Gene 2003; 310 : 67-78. (Pubitemid 36703301)
15. Kim YH, Jha KN, Mandal A, et al. Translation and assembly of CABYR coding region B in fibrous sheath and restriction of calcium binding to coding region A. Dev Biol 2005; 286 : 46-56. (Pubitemid 41394046)
16. Newell AE, Fiedler SE, Ruan JM, et al. Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. Cell Motil Cytoskeleton 2008; 65 : 539-52. (Pubitemid 351956382)
17. Luo C, Xiao X, Liu D, et al. CABYR is a novel cancer-testis antigen in lung cancer. Clin Cancer Res 2007; 13 : 1288-97. (Pubitemid 46424070)
18. Okada T, Akada M, Fujita T, et al. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin Cancer Res 2006; 12 : 191-7. (Pubitemid 43166194)
19. Hsu HC, Lee YL, Cheng TS, et al. Characterization of two non-testis-specific CABYR variants that bind to GSK3beta with a proline-rich extensin-like domain. Biochem Biophys Res Commun 2005; 329 : 1108-17.
20. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277 : 49927-34. (Pubitemid 36014442)
21. Park SG, Lee SM, Jung G. Antisense oligodeoxynucleotides targeted against molecular chaperonin Hsp60 block human hepatitis B virus replication. J Biol Chem 2003; 278 : 39851-7. (Pubitemid 37248547)
22. Cohen P. The role of protein phosphorylation in the hormonal control of enzyme activity. Eur J Biochem 1985; 151 : 439-48. (Pubitemid 16215774)
23. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 1990; 9 : 2431-8.
24. He X, Saint-Jeannet JP, Woodgett JR, Varmus HE, Dawid IB. Glycogen synthase kinase-3 and dorsoventral patterning in xenopus embryos. Nature 1995; 374 : 617-22.
25. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci 2003; 116 : 1175-86. (Pubitemid 36410657)
26. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65 : 391-426. (Pubitemid 32781670)